Landscapes / Companies
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials
Trials
3 active
8 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 1 Dec 2026soonPhase 2 trial completes | |||
| Next date | 1 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Solid Tumor, Epithelial Ovarian Cancer and 4 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021